Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07537374

A Case-Control Observational Study of Peripheral Blood-Derived iPSC Models to Investigate Oligodendrocyte Lineage Development in Children With Williams Syndrome and Healthy Controls

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
6 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
3 Years – 12 Years
Healthy volunteers
Accepted

Summary

This study aims to collect peripheral blood samples from children with Williams syndrome (WS) and healthy children, establish a cell line of induced pluripotent stem cells (iPSCs) derived from the subjects, and further induce and differentiate them into neural progenitor cells (NPCs) and oligodendrocyte lineage cells for in vitro studies on the cellular and molecular mechanisms of WS-related neurodevelopmental abnormalities. Based on previous basic and pre-experimental results, the study focuses on the developmental transition of oligodendrocyte lineage from OPC to pre-OL, immature oligodendrocytes, and mature oligodendrocytes, and specifically evaluates the programs of myelin-related genes, differentiation trajectories, and abnormalities in related pathways such as GTF2I/FZD9, ERK/MAPK, and Wnt/β-catenin. The study design is an independent donor case-control study, and it plans to include 3 children with WS and 3 healthy children. Each sample will be independently sequenced.

Conditions

Interventions

TypeNameDescription
OTHERone-time peripheral blood collectionIn this study, the operation directly involving the subjects was only a one-time peripheral blood collection. The collected biological samples will be used for: * Peripheral blood cell separation * Establishment and characterization of iPSCs * Directed differentiation of NPCs and oligodendrocyte lineages * Immunological, transcriptomic and single-cell transcriptomic analyses

Timeline

Start date
2026-04-01
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2026-04-17
Last updated
2026-04-17

Source: ClinicalTrials.gov record NCT07537374. Inclusion in this directory is not an endorsement.